Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 6 | 2025 | 36 | 1.640 |
Why?
|
| Female | 26 | 2025 | 2523 | 1.500 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2024 | 4 | 1.320 |
Why?
|
| Humans | 30 | 2025 | 4936 | 1.290 |
Why?
|
| Male | 22 | 2025 | 2491 | 1.260 |
Why?
|
| Neoplasms | 3 | 2025 | 90 | 0.980 |
Why?
|
| Middle Aged | 12 | 2025 | 967 | 0.940 |
Why?
|
| Adult | 14 | 2025 | 1567 | 0.920 |
Why?
|
| Single-Domain Antibodies | 1 | 2025 | 1 | 0.900 |
Why?
|
| Fish Diseases | 2 | 2025 | 2 | 0.900 |
Why?
|
| Quantitative Trait Loci | 2 | 2025 | 4 | 0.900 |
Why?
|
| Dendrimers | 1 | 2025 | 6 | 0.890 |
Why?
|
| Polylysine | 1 | 2025 | 6 | 0.890 |
Why?
|
| DNA Fingerprinting | 2 | 2024 | 2 | 0.890 |
Why?
|
| Cannabis | 2 | 2024 | 20 | 0.850 |
Why?
|
| Aged | 10 | 2025 | 703 | 0.820 |
Why?
|
| Animals | 11 | 2025 | 1711 | 0.790 |
Why?
|
| Hordeum | 2 | 2025 | 2 | 0.680 |
Why?
|
| Progesterone | 2 | 2025 | 4 | 0.670 |
Why?
|
| Registries | 3 | 2024 | 22 | 0.660 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 96 | 0.590 |
Why?
|
| Salmo salar | 2 | 2025 | 2 | 0.570 |
Why?
|
| Body Remains | 2 | 2024 | 2 | 0.560 |
Why?
|
| Microsatellite Repeats | 2 | 2024 | 8 | 0.560 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 12 | 0.550 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2024 | 18 | 0.550 |
Why?
|
| Chromosome Mapping | 2 | 2024 | 8 | 0.550 |
Why?
|
| Biomass | 2 | 2025 | 21 | 0.500 |
Why?
|
| Animal Migration | 1 | 2025 | 1 | 0.460 |
Why?
|
| Animals, Wild | 1 | 2025 | 3 | 0.460 |
Why?
|
| Influenza in Birds | 1 | 2025 | 2 | 0.460 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2025 | 2 | 0.460 |
Why?
|
| Bass | 1 | 2025 | 1 | 0.450 |
Why?
|
| Disease Resistance | 1 | 2025 | 1 | 0.450 |
Why?
|
| Interleukin-1 | 1 | 2025 | 1 | 0.450 |
Why?
|
| Asymptomatic Infections | 1 | 2025 | 2 | 0.450 |
Why?
|
| MADS Domain Proteins | 1 | 2025 | 1 | 0.450 |
Why?
|
| Ovule | 1 | 2025 | 1 | 0.450 |
Why?
|
| Interleukins | 1 | 2025 | 2 | 0.450 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2025 | 3 | 0.450 |
Why?
|
| Plant Proteins | 1 | 2025 | 4 | 0.450 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 12 | 0.450 |
Why?
|
| Quercus | 1 | 2025 | 1 | 0.450 |
Why?
|
| Genome, Plant | 1 | 2025 | 5 | 0.450 |
Why?
|
| Blepharoptosis | 1 | 2025 | 1 | 0.450 |
Why?
|
| Lymphatic Metastasis | 1 | 2025 | 1 | 0.450 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2025 | 1 | 0.450 |
Why?
|
| Blinking | 1 | 2025 | 2 | 0.450 |
Why?
|
| Certolizumab Pegol | 1 | 2025 | 1 | 0.450 |
Why?
|
| Pharmacovigilance | 1 | 2025 | 1 | 0.450 |
Why?
|
| Haplotypes | 1 | 2025 | 10 | 0.450 |
Why?
|
| Ivermectin | 1 | 2024 | 1 | 0.450 |
Why?
|
| Copepoda | 1 | 2024 | 1 | 0.450 |
Why?
|
| Household Products | 1 | 2024 | 1 | 0.450 |
Why?
|
| Sulfuric Acids | 1 | 2024 | 1 | 0.450 |
Why?
|
| Drug Resistance | 1 | 2024 | 3 | 0.450 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 6 | 1 | 2024 | 1 | 0.450 |
Why?
|
| Reproductive Health | 1 | 2024 | 1 | 0.450 |
Why?
|
| Mentors | 1 | 2024 | 7 | 0.440 |
Why?
|
| Cystitis, Interstitial | 1 | 2024 | 1 | 0.440 |
Why?
|
| Hematology | 1 | 2024 | 1 | 0.440 |
Why?
|
| Hypertension, Pulmonary | 1 | 2024 | 3 | 0.440 |
Why?
|
| Pelvic Floor | 1 | 2024 | 2 | 0.440 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 10 | 0.440 |
Why?
|
| Herbicides | 1 | 2024 | 2 | 0.440 |
Why?
|
| Natural Language Processing | 1 | 2024 | 6 | 0.440 |
Why?
|
| Patellar Ligament | 1 | 2024 | 1 | 0.440 |
Why?
|
| Zea mays | 1 | 2024 | 2 | 0.440 |
Why?
|
| Blood Transfusion | 1 | 2024 | 1 | 0.440 |
Why?
|
| Cross-Over Studies | 1 | 2025 | 31 | 0.440 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 2 | 0.440 |
Why?
|
| Ventricular Remodeling | 1 | 2024 | 2 | 0.440 |
Why?
|
| Ankle Joint | 1 | 2024 | 5 | 0.440 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 5 | 0.440 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2024 | 5 | 0.440 |
Why?
|
| Achilles Tendon | 1 | 2024 | 4 | 0.440 |
Why?
|
| Guideline Adherence | 1 | 2024 | 3 | 0.440 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 1 | 0.440 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2024 | 2 | 0.440 |
Why?
|
| Electronic Health Records | 1 | 2024 | 16 | 0.440 |
Why?
|
| Faculty, Medical | 1 | 2024 | 6 | 0.440 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2024 | 3 | 0.440 |
Why?
|
| Muscle Strength | 1 | 2024 | 7 | 0.440 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 28 | 0.440 |
Why?
|
| Reproduction | 1 | 2024 | 22 | 0.440 |
Why?
|
| Pyramidal Tracts | 1 | 2024 | 5 | 0.440 |
Why?
|
| Bone and Bones | 1 | 2024 | 16 | 0.440 |
Why?
|
| Neurosurgical Procedures | 1 | 2024 | 9 | 0.440 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2024 | 18 | 0.440 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 12 | 0.440 |
Why?
|
| Hemodynamics | 1 | 2024 | 18 | 0.440 |
Why?
|
| Phylogeny | 1 | 2025 | 59 | 0.440 |
Why?
|
| Climate Change | 1 | 2024 | 21 | 0.430 |
Why?
|
| Veterans | 1 | 2024 | 17 | 0.430 |
Why?
|
| Carbon | 1 | 2024 | 18 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 25 | 0.430 |
Why?
|
| Electromyography | 1 | 2024 | 37 | 0.430 |
Why?
|
| Minority Groups | 1 | 2024 | 35 | 0.430 |
Why?
|
| Glucuronosyltransferase | 1 | 2024 | 30 | 0.430 |
Why?
|
| Medicaid | 1 | 2024 | 29 | 0.430 |
Why?
|
| Machine Learning | 1 | 2024 | 35 | 0.420 |
Why?
|
| DNA | 1 | 2024 | 58 | 0.420 |
Why?
|
| Medicare | 1 | 2024 | 78 | 0.420 |
Why?
|
| Cell Proliferation | 1 | 2024 | 115 | 0.420 |
Why?
|
| Ecosystem | 1 | 2024 | 54 | 0.420 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 43 | 0.420 |
Why?
|
| Sex Chromosomes | 1 | 2024 | 9 | 0.410 |
Why?
|
| Stroke | 1 | 2024 | 48 | 0.410 |
Why?
|
| Quality of Life | 1 | 2024 | 87 | 0.410 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 73 | 0.410 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 262 | 0.400 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 78 | 0.400 |
Why?
|
| Signal Transduction | 1 | 2025 | 216 | 0.390 |
Why?
|
| Retrospective Studies | 4 | 2025 | 341 | 0.390 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2024 | 109 | 0.390 |
Why?
|
| Infant, Newborn | 4 | 2025 | 48 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 197 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 176 | 0.370 |
Why?
|
| Exercise | 1 | 2024 | 173 | 0.370 |
Why?
|
| Genotype | 3 | 2025 | 40 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 55 | 0.320 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 160 | 0.320 |
Why?
|
| Treatment Outcome | 3 | 2025 | 177 | 0.310 |
Why?
|
| Infant | 3 | 2025 | 78 | 0.270 |
Why?
|
| Child, Preschool | 3 | 2025 | 180 | 0.260 |
Why?
|
| Young Adult | 3 | 2025 | 787 | 0.250 |
Why?
|
| Hydroxyurea | 1 | 2025 | 1 | 0.230 |
Why?
|
| Antisickling Agents | 1 | 2025 | 2 | 0.230 |
Why?
|
| Crops, Agricultural | 1 | 2025 | 1 | 0.230 |
Why?
|
| Photosynthesis | 1 | 2025 | 2 | 0.230 |
Why?
|
| Mice | 2 | 2025 | 685 | 0.230 |
Why?
|
| Oligopeptides | 1 | 2025 | 8 | 0.220 |
Why?
|
| Waist Circumference | 1 | 2025 | 8 | 0.220 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 10 | 0.220 |
Why?
|
| Menopause | 1 | 2025 | 4 | 0.220 |
Why?
|
| Drug Carriers | 1 | 2025 | 7 | 0.220 |
Why?
|
| Placenta | 1 | 2024 | 4 | 0.220 |
Why?
|
| Canada | 2 | 2024 | 5 | 0.220 |
Why?
|
| Estradiol | 1 | 2025 | 16 | 0.220 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2024 | 8 | 0.220 |
Why?
|
| Aldehyde Oxidase | 1 | 2024 | 1 | 0.220 |
Why?
|
| Drug Interactions | 1 | 2024 | 8 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 13 | 0.220 |
Why?
|
| Polyethylene Glycols | 1 | 2025 | 27 | 0.220 |
Why?
|
| Adiposity | 1 | 2025 | 20 | 0.220 |
Why?
|
| Picornaviridae | 1 | 2024 | 1 | 0.220 |
Why?
|
| Picornaviridae Infections | 1 | 2024 | 1 | 0.220 |
Why?
|
| Swine Diseases | 1 | 2024 | 1 | 0.220 |
Why?
|
| Immunodominant Epitopes | 1 | 2024 | 1 | 0.220 |
Why?
|
| Epitope Mapping | 1 | 2024 | 1 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 2 | 2024 | 18 | 0.220 |
Why?
|
| Capsid Proteins | 1 | 2024 | 2 | 0.220 |
Why?
|
| Chromatin | 1 | 2024 | 7 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 2 | 2024 | 34 | 0.220 |
Why?
|
| Insulin | 1 | 2025 | 29 | 0.220 |
Why?
|
| Prognosis | 2 | 2025 | 60 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 21 | 0.220 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 27 | 0.220 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 13 | 0.220 |
Why?
|
| Body Mass Index | 1 | 2025 | 98 | 0.220 |
Why?
|
| Prospective Studies | 2 | 2024 | 111 | 0.210 |
Why?
|
| Parents | 1 | 2025 | 58 | 0.210 |
Why?
|
| Risk Factors | 2 | 2025 | 159 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 39 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 184 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 69 | 0.200 |
Why?
|
| Obesity | 1 | 2025 | 115 | 0.200 |
Why?
|
| Models, Biological | 1 | 2024 | 124 | 0.200 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 258 | 0.200 |
Why?
|
| United States | 2 | 2024 | 495 | 0.180 |
Why?
|
| Child | 2 | 2025 | 627 | 0.180 |
Why?
|
| Adolescent | 2 | 2025 | 758 | 0.170 |
Why?
|
| Carbon Dioxide | 2 | 2025 | 9 | 0.170 |
Why?
|
| Pregnancy | 2 | 2025 | 89 | 0.160 |
Why?
|
| New Zealand | 1 | 2025 | 1 | 0.110 |
Why?
|
| Charadriiformes | 1 | 2025 | 1 | 0.110 |
Why?
|
| Islands | 1 | 2025 | 1 | 0.110 |
Why?
|
| Epidemiological Monitoring | 1 | 2025 | 1 | 0.110 |
Why?
|
| Influenza A virus | 1 | 2025 | 3 | 0.110 |
Why?
|
| Genomic Structural Variation | 1 | 2025 | 1 | 0.110 |
Why?
|
| Birds | 1 | 2025 | 5 | 0.110 |
Why?
|
| Lymphoid Tissue | 1 | 2025 | 1 | 0.110 |
Why?
|
| Prions | 1 | 2025 | 1 | 0.110 |
Why?
|
| Sheep Diseases | 1 | 2025 | 1 | 0.110 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 2025 | 1 | 0.110 |
Why?
|
| PrPSc Proteins | 1 | 2025 | 1 | 0.110 |
Why?
|
| Edible Grain | 1 | 2025 | 1 | 0.110 |
Why?
|
| Sheep | 1 | 2025 | 3 | 0.110 |
Why?
|
| Triticum | 1 | 2025 | 3 | 0.110 |
Why?
|
| United Kingdom | 1 | 2025 | 7 | 0.110 |
Why?
|
| Chromosomes, Plant | 1 | 2025 | 1 | 0.110 |
Why?
|
| Synteny | 1 | 2025 | 2 | 0.110 |
Why?
|
| Genes, Plant | 1 | 2025 | 4 | 0.110 |
Why?
|
| Multigene Family | 1 | 2025 | 5 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2025 | 2 | 0.110 |
Why?
|
| Reference Standards | 1 | 2025 | 12 | 0.110 |
Why?
|
| Cattle | 1 | 2025 | 18 | 0.110 |
Why?
|
| Survival Rate | 1 | 2025 | 14 | 0.110 |
Why?
|
| Molecular Sequence Annotation | 1 | 2025 | 12 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 9 | 0.110 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2025 | 1 | 0.110 |
Why?
|
| Japan | 1 | 2025 | 4 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2025 | 5 | 0.110 |
Why?
|
| Career Choice | 1 | 2024 | 1 | 0.110 |
Why?
|
| DNA Degradation, Necrotic | 1 | 2024 | 1 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2025 | 32 | 0.110 |
Why?
|
| Hydrochloric Acid | 1 | 2024 | 1 | 0.110 |
Why?
|
| Eyelids | 1 | 2025 | 10 | 0.110 |
Why?
|
| Detergents | 1 | 2024 | 2 | 0.110 |
Why?
|
| Sodium Hypochlorite | 1 | 2024 | 3 | 0.110 |
Why?
|
| Immersion | 1 | 2024 | 3 | 0.110 |
Why?
|
| Disinfectants | 1 | 2024 | 3 | 0.110 |
Why?
|
| Systematized Nomenclature of Medicine | 1 | 2024 | 2 | 0.110 |
Why?
|
| Cardiac Output | 1 | 2024 | 2 | 0.110 |
Why?
|
| Cardiac Catheterization | 1 | 2024 | 3 | 0.110 |
Why?
|
| Myalgia | 1 | 2024 | 1 | 0.110 |
Why?
|
| Fever | 1 | 2024 | 2 | 0.110 |
Why?
|
| Tranexamic Acid | 1 | 2024 | 1 | 0.110 |
Why?
|
| Dronabinol | 1 | 2024 | 1 | 0.110 |
Why?
|
| Transferases | 1 | 2024 | 1 | 0.110 |
Why?
|
| DNA, Plant | 1 | 2024 | 1 | 0.110 |
Why?
|
| Humulus | 1 | 2024 | 1 | 0.110 |
Why?
|
| Genotyping Techniques | 1 | 2024 | 1 | 0.110 |
Why?
|
| Electrophoresis, Capillary | 1 | 2024 | 2 | 0.110 |
Why?
|
| Neutropenia | 1 | 2024 | 2 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2025 | 7 | 0.110 |
Why?
|
| Rest | 1 | 2024 | 9 | 0.110 |
Why?
|
| Anemia | 1 | 2024 | 2 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2024 | 5 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2025 | 28 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 7 | 0.110 |
Why?
|
| Carbon Sequestration | 1 | 2024 | 2 | 0.110 |
Why?
|
| Baltimore | 1 | 2024 | 1 | 0.110 |
Why?
|
| Knee Joint | 1 | 2024 | 6 | 0.110 |
Why?
|
| Current Procedural Terminology | 1 | 2024 | 1 | 0.110 |
Why?
|
| District of Columbia | 1 | 2024 | 2 | 0.110 |
Why?
|
| Neurosurgeons | 1 | 2024 | 2 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2024 | 1 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2025 | 26 | 0.110 |
Why?
|
| Muscle Contraction | 1 | 2024 | 11 | 0.110 |
Why?
|
| Fertility | 1 | 2024 | 6 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2024 | 23 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2024 | 14 | 0.110 |
Why?
|
| Mentoring | 1 | 2024 | 13 | 0.110 |
Why?
|
| Proteome | 1 | 2024 | 7 | 0.110 |
Why?
|
| Genomics | 1 | 2025 | 38 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2024 | 11 | 0.110 |
Why?
|
| Static Electricity | 1 | 2024 | 15 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2025 | 31 | 0.110 |
Why?
|
| Oculomotor Muscles | 1 | 2025 | 15 | 0.110 |
Why?
|
| Action Potentials | 1 | 2024 | 18 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 83 | 0.110 |
Why?
|
| Sepsis | 1 | 2024 | 4 | 0.110 |
Why?
|
| Fatigue | 1 | 2024 | 9 | 0.110 |
Why?
|
| Community Health Services | 1 | 2024 | 6 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 19 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2024 | 43 | 0.110 |
Why?
|
| Upper Extremity | 1 | 2024 | 9 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 8 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2024 | 21 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2025 | 44 | 0.110 |
Why?
|
| Hospitalization | 1 | 2024 | 38 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 17 | 0.110 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2024 | 17 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2025 | 34 | 0.110 |
Why?
|
| Soil | 1 | 2024 | 25 | 0.110 |
Why?
|
| Exercise Test | 1 | 2024 | 41 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 32 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2025 | 115 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2024 | 98 | 0.110 |
Why?
|
| Sex Factors | 1 | 2024 | 76 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 47 | 0.110 |
Why?
|
| Time Factors | 1 | 2024 | 163 | 0.110 |
Why?
|
| Characiformes | 1 | 2024 | 1 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2025 | 67 | 0.100 |
Why?
|
| Fishes | 1 | 2024 | 7 | 0.100 |
Why?
|
| Genome | 1 | 2024 | 20 | 0.100 |
Why?
|
| Sex Determination Processes | 1 | 2024 | 11 | 0.100 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 34 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 269 | 0.100 |
Why?
|
| Brain | 1 | 2025 | 195 | 0.090 |
Why?
|
| Plant Breeding | 1 | 2025 | 1 | 0.060 |
Why?
|
| Chlorophyll | 1 | 2025 | 1 | 0.060 |
Why?
|
| Agriculture | 1 | 2025 | 5 | 0.060 |
Why?
|
| Plant Leaves | 1 | 2025 | 2 | 0.060 |
Why?
|
| Ozone | 1 | 2025 | 3 | 0.060 |
Why?
|
| Weight Loss | 1 | 2025 | 7 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2025 | 1 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2025 | 2 | 0.060 |
Why?
|
| Osteoarthritis, Knee | 1 | 2025 | 4 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2024 | 2 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2025 | 14 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2025 | 14 | 0.060 |
Why?
|
| Unsupervised Machine Learning | 1 | 2024 | 1 | 0.060 |
Why?
|
| Clone Cells | 1 | 2024 | 4 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2024 | 6 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2024 | 6 | 0.060 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2024 | 4 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 8 | 0.060 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2024 | 9 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2024 | 13 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2024 | 15 | 0.060 |
Why?
|
| Overweight | 1 | 2025 | 40 | 0.050 |
Why?
|
| Motion | 1 | 2024 | 21 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 18 | 0.050 |
Why?
|
| Macrophages | 1 | 2024 | 26 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 50 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 35 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2024 | 49 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 23 | 0.050 |
Why?
|
| Biomarkers | 1 | 2025 | 81 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 48 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 37 | 0.050 |
Why?
|
| Transcriptome | 1 | 2024 | 43 | 0.050 |
Why?
|
| Liver | 1 | 2024 | 49 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2024 | 75 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 46 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2024 | 161 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 97 | 0.050 |
Why?
|
| Mutation | 1 | 2024 | 132 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 225 | 0.050 |
Why?
|